Psychedelics and the Future of Anxiety Relief
In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety. He shares his personal journey through psychiatry and addiction medicine, discussing the limitations of traditional treatments and the hope that psychedelics might bring. We dive into MindMed’s research on how LSD could impact generalized anxiety disorder (GAD), with Dr. Karlin explaining how it works and the importance of therapy alongside these treatments. This insightful conversation explores how MindMed is leading the way in developing new solutions for mental health, which could change the way we treat anxiety.
Episode 1 of the Power to the Patients podcast, hosted by Brandon Li, titled "Psychedelics and the Future of Anxiety Relief" was published on September 19, 2024 and runs 38 minutes.
September 19, 2024 ·38m · Power to the Patients
Summary
In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety. He shares his personal journey through psychiatry and addiction medicine, discussing the limitations of traditional treatments and the hope that psychedelics might bring. We dive into MindMed’s research on how LSD could impact generalized anxiety disorder (GAD), with Dr. Karlin explaining how it works and the importance of therapy alongside these treatments. This insightful conversation explores how MindMed is leading the way in developing new solutions for mental health, which could change the way we treat anxiety.
Episode Description
Similar Episodes
Apr 9, 2026 ·12m
Apr 5, 2026 ·5m
Apr 3, 2026 ·8m
Mar 30, 2026 ·9m
Mar 28, 2026 ·8m